All Health Care News
Top stories summarized by our editors
12/15/2017

Maine's juvenile justice system needs a full reassessment, an outside review panel concluded after examining the state's only youth correctional facility.
The Center for Children's Law and Policy said too many young people with mental health conditions are housed in at the facility, which it said is chronically understaffed and ill-equipped to serve them.

12/15/2017

Facing long patient waiting lists, West Virginia mental health providers are hesitant to sign on to a program where police send minor offenders with addictions to treatment rather than jail. The Law Enforcement Assisted Diversion initiative has had success in Charleston, but efforts to expand it have run into a statewide shortage of mental health professionals.

Full Story:
Stateline
12/15/2017

The US Department of Education is seeking public feedback on its proposal to delay the implementation of a rule that requires districts to consider racial or ethnic disparities in special education. The department is seeking the two-year delay to give it time to consider the elimination of the rule, which was set to take effect in the 2018-19 school year.

More Summaries:
US Department of Education
12/15/2017

Maine should immediately expand drug treatment and give priority to children, the uninsured and the incarcerated, a task force on the opioid epidemic says. State lawmakers may vote on opioid-related bills next month.

12/15/2017

The Biologics Price Competition and Innovation Act does not compel biosimilar-drug makers to provide a copy of marketing applications and related manufacturing information to reference product makers after the FDA accepts the application for review, according to a federal appeals court.

More Summaries:
FDA
12/15/2017

The House and Senate are unlikely to take swift action to reduce drug prices, comments by Reps. Greg Walden, R-Ore., and Michael Burgess, R-Texas, suggest.

More Summaries:
Greg Walden, Michael Burgess, Senate
12/15/2017

As lawmakers debate ways to bring down drug prices, the drug industry lobby brushed aside the notion that pay-for-delay, patent evergreening and other industry practices to protect profits contribute to the problem. "I don't think it's in the top 100 problems plaguing the health care system," said Pharmaceutical Research and Manufacturers of America CEO Stephen Ubl, later adding: "The system is fundamentally sound and is leading to greater competition."

12/15/2017

Pfizer will not immediately market Ixifi, a newly approved biosimilar version of Johnson & Johnson's Remicade, in the US, preferring instead to focus on its existing biosimilar, Inflectra, Pfizer spokesperson Thomas Biegi said.

Full Story:
Regulatory Focus
More Summaries:
Pfizer, Johnson & Johnson, Ixifi
12/15/2017

A study in Arthritis Care and Research found an association between severe obesity and elevated C-reactive protein level and erythrocyte sedimentation rate among women with and without rheumatoid arthritis. However, among men with RA, low BMI was tied to higher C-reactive protein levels and ESR, according to the findings based on two rheumatoid arthritis cohorts involving a total of 2,103 patients.

12/15/2017

CDC researchers followed 19 Brazilian infants with Zika-related microcephaly until ages 19 months to 24 months and found all had one or more of six adverse outcomes, which were sleeping problems, feeding challenges, vision and hearing abnormalities, severe motor impairment and nonfebrile seizures. The findings in the agency's Morbidity and Mortality Weekly Report also showed three to five adverse events in 12 of the children, while two had experienced all of the adverse outcomes.

More Summaries:
CDC, microcephaly, Zika